Table 5 Demographics of fever clinic cohort in July-August 2024

From: Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk assessment

 

Total

SARS-CoV-2 (−)

SARS-CoV-2 (+)

Gender

Male

178 (46.2%)

163 (42.3%)

15 (3.9%)

Female

207 (53.8%)

187(48.6%)

20 (5.2%)

Age

0-17

21 (5.5%)

21 (5.5%)

0 (0.0%)

18-59

264 (68.5%)

250 (64.9%)

14 (3.6%)

>59

100 (26.0%)

79 (20.5%)

21 (5.5%)

Back to article page